` 3349 (Cosmos Pharmaceutical Corp) vs Nikkei 225 Comparison - Alpha Spread

3349
vs
N
Nikkei 225

Over the past 12 months, Cosmos Pharmaceutical Corp has underperformed Nikkei 225, delivering a return of -1% compared to the Nikkei 225's +58% growth.

Stocks Performance
3349 vs Nikkei 225

Loading
3349
Nikkei 225
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
3349 vs Nikkei 225

Loading
3349
Nikkei 225
Difference
www.alphaspread.com

Performance By Year
3349 vs Nikkei 225

Loading
3349
Nikkei 225
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Cosmos Pharmaceutical Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Cosmos Pharmaceutical Corp
Glance View

Market Cap
555B JPY
Industry
Retail

In the bustling landscape of Japan's healthcare and beauty industry, Cosmos Pharmaceutical Corp. stands out as a compelling story of strategic ambition and adaptive growth. Established in 1976, the company emerged in Fukuoka, swiftly evolving from a traditional pharmacy into one of the country's most recognized chains of drugstores. Cosmos carved its niche by blending the conveniences of modern retailing with a diverse array of pharmaceutical, health, and personal care products. It's not merely a matter of selling medication; Cosmos transformed the drugstore experience, offering a comprehensive range of products including cosmetics, daily essentials, and food items, which cater to the holistic needs of its customers. This diversification strategy bolsters revenue streams and mitigates risks associated with dependency on any single product category. The company's financial success is further driven by its efficient use of technology and economy of scale. Cosmos Pharmaceutical masterfully implements IT solutions and logistics optimization to manage its expansive network of stores, which number in the thousands across Japan. This not only reduces operational costs but also ensures timely restocking, enhancing consumer satisfaction. The chain's "Everyday Low Pricing" strategy is pivotal to its profitability, drawing in cost-conscious customers and fostering high sales volume. By maintaining streamlined operations and a customer-centric approach, Cosmos cultivates a symbiotic relationship between growth and efficiency, allowing it to thrive in a competitive market and continue its expansion across Japan.

Intrinsic Value
8 788.66 JPY
Undervaluation 21%
Intrinsic Value
Price
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett